SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 305 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $542,000 | +24.3% | 4,901 | -12.7% | 0.05% | +19.0% |
| Q2 2021 | $436,000 | -44.7% | 5,612 | -47.0% | 0.04% | -25.0% |
| Q1 2021 | $789,000 | +34.4% | 10,586 | +207.4% | 0.06% | -11.1% |
| Q4 2020 | $587,000 | +34.3% | 3,444 | +26.4% | 0.06% | +26.0% |
| Q2 2020 | $437,000 | -9.0% | 2,725 | -32.3% | 0.05% | +85.2% |
| Q1 2019 | $480,000 | -60.9% | 4,027 | -64.2% | 0.03% | -59.1% |
| Q4 2018 | $1,227,000 | +57.9% | 11,240 | +91.1% | 0.07% | +94.1% |
| Q2 2018 | $777,000 | +18.4% | 5,881 | -33.6% | 0.03% | -2.9% |
| Q1 2018 | $656,000 | – | 8,857 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |